Table 2 The genotype distribution of HTTLPR between TN patients controls
Genotype | TN | Control | Adjusted OR | 95% CI | Adjusted P | ||||
|---|---|---|---|---|---|---|---|---|---|
5-HTTLPR | Long-long | 58 | 23.77% | 103 | 36.79% | 1.000 | |||
Long-short | 99 | 40.57% | 129 | 46.07% | 1.363 | 0.900 | 2.064 | 0.143 | |
Short-short | 87 | 35.66% | 48 | 17.14% | 3.219 | 1.997 | 5.187 | 0.000 | |
Long | 215 | 44.06% | 335 | 59.82% | 1.000 | ||||
short | 273 | 55.94% | 225 | 40.18% | 1.891 | 1.478 | 2.418 | 0.045 | |
rs25531 | AA | 68 | 27.87% | 75 | 26.79% | 1.000 | |||
AG | 114 | 46.72% | 135 | 48.21% | 0.931 | 0.617 | 1.406 | 0.735 | |
GG | 62 | 25.41% | 70 | 25.00% | 0.977 | 0.608 | 1.569 | 0.923 | |
A | 250 | 51.23% | 285 | 50.89% | 1.000 | ||||
G | 238 | 48.77% | 275 | 49.11% | 0.987 | 0.774 | 1.258 | 0.913 | |